BioSpace News Archive

Policy

NeuroVive Announces Settlement in Dispute With CicloMulsion AG

NeuroVive Pharmaceutical AB announced that it has fully and finally settled the dispute with CicloMulsion AG regarding certain pharmaceutical technology.

December 16, 2019
·
3 min read
Business

Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

Algernon Pharmaceuticals Inc. is pleased to announce that Dr. Martin Kolb, a leading global scientific expert and clinician in the area of idiopathic pulmonary fibrosis, has joined the Algernon Medical and Scientific Advisory Board.

December 16, 2019
·
4 min read
Business

Molina Healthcare Announces Fourth Quarter and Year-End 2019 Earnings Release and Conference Call Dates

Molina Healthcare, Inc. announced details for the release of its results for the fourth quarter and year ended December 31, 2019.

December 16, 2019
·
1 min read
Drug Development

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder

Demonstrated rapid, durable, and statistically significant improvement in depressive symptoms as measured by MADRS total score compared to placebo (p=0.002 on primary endpoint)

December 16, 2019
·
17 min read
Business

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with continued improving gross margins

Polydex Pharmaceuticals Limited announces 3rd quarter financial results.

December 16, 2019
·
2 min read
Pharm Country

Work Group Releases Five Principles for Redesigning CMS’ Oncology Care Model

An expert Work Group released a white paper outlining recommendations for the next iteration of the Centers for Medicare and Medicaid Services ' Oncology Care Model.

December 16, 2019
·
3 min read
Policy

Ambry Genetics Receives New York State Approval to Offer Paired RNA and DNA Genetic Testing for Hereditary Cancer Risk

+RNAinsight™ is now available for New York patients, and will help identify thousands more patients at increased risk for cancer

December 16, 2019
·
3 min read
Deals

Danaher Announces Preliminary Results Of Envista Exchange Offer

Danaher Corporation announced the preliminary results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation owned by Danaher.

December 16, 2019
·
5 min read
L&T Technology Services Ltd Develops the World’s First Cost-Effective Robotic Endo-Training Kit

LTTS felicitated at 8th Foundation Day of Global Innovation & Technology Alliance

December 16, 2019
·
3 min read
Biotech Beach

ChromaDex Wins Nutritional Outlook’s 2019 “Best of Industry” Ingredient Supplier Award for Niagen®

ChromaDex Corp. (NASDAQ:CDXC) announced today that Nutritional Outlook®, a leading publication for the nutraceuticals industry, recently awarded ChromaDex the 2019 “Best of Industry Award,” in the “Ingredient Supplier” category, for Niagen® (nicotinamide riboside).

December 16, 2019
·
4 min read